Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and Venlafaxine XR in Generalized Anxiety Disorder
NCT00151450Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in generalized anxiety disorder (GAD) (3 arms), sponsored by Viatris. Primary endpoint: Hamilton Anxiety Rating Scale at 8 weeks. Started Mar 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00151450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151450.